THR-β agonist 4

THR-β agonist 4

• CAS Number: 2673409-25-9
• UNSPSC Description: THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1].
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Applications: Metabolism-sugar/lipid metabolism
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/thr-β-agonist-4.html
• Solubility: 10 mM in DMSO
• Smiles: O=C1NC(N(C2=CC(Cl)=C(C(Cl)=C2)OC3=NC=C(C(S(=O)(NC)=O)=C3)O)N=C1C(F)F)=O
• Molecular Weight: 510.26
• References & Citations: [1]Jingye Zhou, et al. Substituted triazinones as thyroid hormone receptor agonists. Patent WO2021143706A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported